INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 92 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $87,922 | -64.4% | 226,021 | -59.2% | 0.00% | -66.7% |
Q2 2023 | $247,131 | +222540.5% | 553,484 | +310.5% | 0.00% | +50.0% |
Q1 2023 | $111 | -48.8% | 134,820 | -3.3% | 0.00% | -50.0% |
Q4 2022 | $217 | -99.9% | 139,397 | -29.1% | 0.00% | -55.6% |
Q2 2022 | $340,000 | +89.9% | 196,533 | +295.2% | 0.01% | +125.0% |
Q1 2022 | $179,000 | -88.9% | 49,734 | -84.6% | 0.00% | -85.2% |
Q4 2021 | $1,617,000 | -17.5% | 323,968 | +18.3% | 0.03% | -15.6% |
Q3 2021 | $1,961,000 | +112.2% | 273,854 | +174.6% | 0.03% | +88.2% |
Q2 2021 | $924,000 | +293.2% | 99,721 | +391.2% | 0.02% | +70.0% |
Q3 2020 | $235,000 | -50.7% | 20,301 | +14.8% | 0.01% | -58.3% |
Q2 2020 | $477,000 | +182.2% | 17,690 | -22.1% | 0.02% | +60.0% |
Q1 2020 | $169,000 | -46.7% | 22,712 | -54.6% | 0.02% | +87.5% |
Q3 2017 | $317,000 | +27.8% | 50,000 | +86.6% | 0.01% | +60.0% |
Q2 2016 | $248,000 | -43.4% | 26,801 | -46.7% | 0.01% | -54.5% |
Q1 2016 | $438,000 | +403.4% | 50,305 | +232.8% | 0.01% | +266.7% |
Q3 2015 | $87,000 | -27.5% | 15,116 | +23.7% | 0.00% | -25.0% |
Q3 2014 | $120,000 | – | 12,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|